Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1199809-32-9

Post Buying Request

1199809-32-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1199809-32-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1199809-32-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,9,8,0 and 9 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1199809-32:
(9*1)+(8*1)+(7*9)+(6*9)+(5*8)+(4*0)+(3*9)+(2*3)+(1*2)=209
209 % 10 = 9
So 1199809-32-9 is a valid CAS Registry Number.

1199809-32-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name PSI-352938

1.2 Other means of identification

Product number -
Other names 6-ethoxy-9-((2R,4aR,6R,7R,7aR)-7-fluoro-2-isopropoxy-7-methyl-2-oxohexahydro-2,5-furo[3,2d][1,3,2]dioxaphosphinin-6-yl)-9H-purine-2-ylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1199809-32-9 SDS

1199809-32-9Downstream Products

1199809-32-9Relevant articles and documents

The synthesis of hydroxyaminopurine nucleosied (by machine translation)

-

, (2016/10/10)

A compound or salt thereof having the following structure useful for the treatment of hepatitis C virus (HCV): wherein R 7 is C 1-6 alkyl or C 3-6 cycloalkyl and R 8 is -O(C 1-6 alkyl) or -O(C 3-6 cycloalkyl).

2′-Deoxy-2′-α-fluoro-2′-β-C-methyl 3′,5′-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: Discovery of PSI-352938

Reddy, P. Ganapati,Bao, Donghui,Chang, Wonsuk,Chun, Byoung-Kwon,Du, Jinfa,Nagarathnam, Dhanapalan,Rachakonda, Suguna,Ross, Bruce S.,Zhang, Hai-Ren,Bansal, Shalini,Espiritu, Christine L.,Keilman, Meg,Lam, Angela M.,Niu, Congrong,Steuer, Holly Micolochick,Furman, Phillip A.,Otto, Michael J.,Sofia, Michael J.

scheme or table, p. 7376 - 7380 (2011/02/28)

A series of novel 2′-deoxy-2′-α-fluoro-2′-β-C- methyl 3′,5′-cyclic phosphate nucleotide prodrug analogs were synthesized and evaluated for their in vitro anti-HCV activity and safety. These prodrugs demonstrated a 10-100-fold greater potency than the parent nucleoside in a cell-based replicon assay due to higher cellular triphosphate levels. Our structure-activity relationship (SAR) studies provided compounds that gave high levels of active triphosphate in rat liver when administered orally to rats. These studies ultimately led to the selection of the clinical development candidate 24a (PSI-352938).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1199809-32-9